... IItrial) regarding safety, immunogenicity and preliminary efficacy. Materials and methodsTrial DesignFor this analysis, the 40 all vaccinated patients from thephase II clinical trial immunized ... 16.ResultsTwo separate studies were compared to assess the impact of high dose vaccination at multiple anatomic sites interms of imm unogenicity, safety and preliminary efficacy of CimaVax-EGF in advanced ... J,Zhang Y, Ranganathan R, Chapman PB, Krown SE, Livingston PO,Heywood M, Riviere I, Panageas KS, Terzulli SL, Perales MA: Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.Mol...